In this article, we take a look at the 7 best stocks under $20 according to billionaire Andreas Halvorsen’s Viking Global.
Viking Global was founded by Norwegian-born Andreas Halvorsen who became a billionaire growing the fund since its inception in 1999. Mr. Halvorsen still manages the fund as of today, with the majority of the funds being allocated in standard individual equities.
Viking Global Investors is a Connecticut-based hedge fund, that specializes in both early-stage companies and mature equities. Billionaire Andreas Halvorsen manages over $32.9 billion in 13F securities through Viking Global.
Ole Andreas Halvorsen was born in Norway in 1961. Mr. Halvorsen attended Williams College, where he was a member of the ski team, and graduated in 1986 with a degree in economics. He went on to receive his MBA from the Stanford University Graduate School of Business in 1990.
Among billionaire Andreas Halvorsen’s top stock picks that are under $20, the most notable ones are Edgewise Therapeutics, Inc. (NASDAQ:EWTX) and Pharvaris N.V. (NASDAQ:PHVS). The billionaire’s top five holdings include Microsoft Corporation (NASDAQ:MSFT), Amazon.com, Inc. (NASDAQ:AMZN), and General Electric Company (NYSE:GE).
Andreas Halvorsen of Viking Global
While Andreas Halvorsen’s reputation remains intact, the same can’t be said of the hedge fund industry as a whole, as its reputation has been tarnished in the last decade during which its hedged returns couldn’t keep up with the unhedged returns of the market indices. On the other hand, Insider Monkey’s research was able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 86 percentage points since March 2017. Between March 2017 and July 2021, our monthly newsletter’s stock picks returned 186.1%, vs. 100.1% for the SPY. Our stock picks outperformed the market by more than 86 percentage points (see the details here). That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to. You can subscribe to our free newsletter on our homepage to receive our stories in your inbox.
Our Methodology:
With this context in mind, here is our list of the 7 best stocks under $20 according to billionaire Andreas Halvorsen’s Viking Global. These were ranked according to the investment portfolio of Viking Global at the end of the second quarter of 2021. We picked these stocks from the Q2 portfolio of the billionaire’s fund.
Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global
7. Gracell Biotechnologies Inc. (NASDAQ:GRCL)
Stake Value of Viking Global: $17,294,000
Share Price: $13.45
Percentage of Viking Global’s 13F Portfolio: 0.05
Number of Hedge Fund Holders: 9
Gracell Biotechnologies Inc. (NASDAQ:GRCL) is a clinical-stage biopharmaceutical company that primarily discovers and develops cell therapies for the treatment of cancer in the People’s Republic of China. It also has a portfolio of early-stage product candidates targeting various cancer indications, such as ovarian cancer and breast cancer. Gracell Biotechnologies Inc. was founded in 2017 and is headquartered in Suzhou, China.
Towards the end of the second quarter of 2021, Piper Sandler analyst Joseph Catanzaro reiterated an Overweight rating on Gracell Biotechnologies Inc. with a $40 price target on the shares. The analyst stated that he sees a “clear line of sight for value creation” at Gracell Biotechnologies Inc..
As of the second quarter of 2021, billionaire Andreas Halvorsen owns over 1.33 million shares in Gracell Biotechnologies Inc.. The total stake the billionaire has in the company is worth roughly $17.3 million.
Microsoft Corporation, Amazon.com, Inc., and General Electric Company make up the top five holdings of Mr. Halvorsen’s Viking Global. But, if you are looking for stocks under $20, Gracell Biotechnologies Inc. is a stock to invest in according to billionaire Andreas Halvorsen.
6. Orion Acquisition Corp. (NASDAQ:OHPA)
Stake Value of Viking Global: $35,686,000
Share Price: $9.74
Percentage of Viking Global’s 13F Portfolio: o.1%
Orion Acquisition Corp. (NASDAQ:OHPA) is a special purpose acquisition company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry.
This March, Orion Acquisition Corp. announced that it closed its upsized initial public offering of 41.4 million units at a price of $10.00 per unit. Total gross proceeds from the offering were $414,000,000, before deducting underwriting discounts and commissions and other offering expenses. Credit Suisse Securities (USA) LLC acted as book-running manager for the offering.
5. Mudrick Capital Acquisition Corporation II (NASDAQ:MUDS)
Stake Value of Viking Global: $37,983,000
Share Price: $9.95
Percentage of Viking Global’s 13F Portfolio: o.11%
Mudrick Capital Acquisition Corporation II (NASDAQ:MUDS) does not have significant operations. Rather, it focuses on affecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
As of the second quarter of 2021, Mr. Halvorsen owns more than 3 million shares of Mudrick Capital Acquisition Corporation II, which come out to a stake value of $37.9 million.
Mudrick Capital Acquisition Corporation II makes up 0.11% of Mr. Halvorsen’s 13F portfolio.
4. Pharvaris N.V. (NASDAQ:PHVS)
Stake Value of Viking Global: $43,454,000
Share Price: $15.72
Percentage of Viking Global’s 13F Portfolio: 0.13%
Number of Hedge Fund Holders: 8
Pharvaris N.V. operates as a clinical-stage biopharmaceutical company, focused on the development and commercialization of therapies for rare diseases. The company has operations in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is headquartered in Leiden, the Netherlands
According to the latest 13F filings, billionaire Andreas Halvorsen has stakes of $43.4 million in Pharvaris N.V.. Mr. Halvorsen owns more than 2.39 million shares in the company, which represents 0.13% of his investment portfolio.
At the end of the second quarter of 2021, 8 out of the 873 hedge funds tracked by Insider Monkey held stakes in Pharvaris N.V. worth $83.4 million. This is compared to 11 positions in the prior quarter, with stakes amounting to roughly $137 million.
3. Talaris Therapeutics, Inc. (NASDAQ:TALS)
Stake Value of Viking Global: $48,324,000
Share Price: $14.87
Percentage of Viking Global’s 13F Portfolio: 0.14%
Number of Hedge Fund Holders: 16
Talaris Therapeutics, Inc. (NASDAQ:TALS) operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.
This June, Evercore ISI analyst Josh Schimmer initiated coverage of Talaris Therapeutics, Inc. with an Outperform rating and $35 price target.
According to Q2 filings, Mr. Halvorsen owns over 3.28 million shares of Talaris Therapeutics, Inc.. This amounts to a total stake value of $48.3 million which covers an impressive 0.14% of the billionaire’s investment portfolio.
By the end of the second quarter of 2021, 16 hedge funds out of the 873 tracked by Insider Monkey held stakes in Talaris Therapeutics, Inc. worth more than $150.4 million.
2. Edgewise Therapeutics, Inc. (NASDAQ:EWTX)
Stake Value of Viking Global: $58,172,000
Share Price: $17.30
Percentage of Viking Global’s 13F Portfolio: 0.17%
Number of Hedge Fund Holders: 15
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb-girdle muscular dystrophies. Edgewise Therapeutics, Inc. develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
In the second quarter of 2021, Wedbush analyst Laura Chico initiated coverage of Edgewise Therapeutics, Inc. with an Outperform rating and $38 price target.
As of the second quarter of 2021, Mr. Halvorsen has stakes worth more than $58 million in Edgewise Therapeutrics, Inc.. He owns over 2.72 million shares in the company which accounts for 0.17% of his 13F portfolio.
By the end of the second quarter of 2021, 15 hedge funds out of the 873 tracked by Insider Monkey held stakes in Edgewise Therapeutics, Inc. worth $688.6 million. This is compared to 16 positions in the first quarter with stakes of more than $1 billion.
1. ICICI Bank Limited (NYSE:IBN)
Stake Value of Viking Global: $360,312,000
Share Price: $18.88
Percentage of Viking Global’s 13F Portfolio: 1.09%
Number of Hedge Fund Holders: 28
ICICI Bank Limited (NYSE:IBN) provides various banking products and financial services in India and internationally. It operates through Retail Banking, Wholesale Banking, Treasury, Other Banking, Life insurance, General insurance, and other segments. ICICI Bank Limited was founded in 1955 and is headquartered in Mumbai, India.
ICICI Bank Limited is a new addition to billionaire Andreas Halvorsen’s investment portfolio. According to the latest 13F filings, Mr. Halvorsen owns over 21 million shares of ICICI Bank Limited which amounts to a stake value of $360.3 million.
By the end of the second quarter of 2021, 28 hedge funds out of the 873 tracked by Insider Monkey held stakes in ICICI Bank Limited worth $2.47 billion. This is compared to 31 positions in the first quarter with stakes of more than $1.90 billion.
See also 10 Best Stocks Under $10 to Buy Right Now and 10 Best Dividend Paying Stocks to Buy Under $50.
Follow Insider Monkey on Twitter
Suggested articles:
- 10 Best Dividend Stocks Under $20
- 10 Best Small-Cap Biotech Stocks Under $10 in 2021
- 10 Best Biotech Stocks Under $6 in 2021
This article is originally published at Insider Monkey.
